PatientsLikeMe : Epzicom Treatment Evaluations

Select a community: All Communities

All Communities
Neurological Conditions
MS (Multiple Sclerosis)
Parkinson’s Disease
ALS (Amyotrophic Lateral Sclerosis) / MND (Motor Neuron Disease)
PLS (Primary Lateral Sclerosis)
PMA (Progressive Muscular Atrophy)
PSP (Progressive Supranuclear Palsy)
CBD (Corticobasal Degeneration)
MSA (Multiple System Atrophy)
Devic’s Neuromyelitis Optica
Neuroendocrine Conditions
Fibromyalgia
Mood Conditions
Anxiety
Bipolar
Depression
Obsessive-Compulsive Disorder
Post-Traumatic Stress Disorder
Immune Conditions
HIV/AIDS

Home > Epzicom Treatment Evaluations

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

See full Epzicom Community Report

One of 5 patient evaluations for Epzicom

AmunRa65

Sex: M

Mental Symptoms: none

Physical Symptoms: mild

Advanced Symptoms/Infections/Cancers: mild

430

VL 6.2M

See profile
by AmunRa65
Oct 10, 2008

dosage:: 600 mg-300 mg daily
time on dosage:: about 3 years
purpose:: Support another treatment

11d48e45ad77b3134801916d735b635ea375da3e

EfficacyMajor
Side-effectsNone
AdherenceAlways
BurdenNone

Support another treatment

0 helpful marks

PatientsLikeMe ™